Although cerebrovascular factors are the second leading cause of cognitive impairment and dementia in elderly, the precise spatial and temporal trajectories of vascular decline in aging have not been fully characterized. With an advanced cerebrovascular reactivity (CVR) MRI technique that specifically informs vascular stiffness and dilatory ability of cerebral vessels, we present four-year longitudinal CVR data measured in 116 healthy individuals (20-88 years of age). Our data revealed a spatial heterogeneity in vascular decline in aging (p ¼ 0.003), in that temporal lobe showed the fastest rate of longitudinal CVR decline, followed by parietal and frontal lobes. The rate of CVR decline was also age-dependent. Middle age, not older age, manifested the fastest rate of longitudinal CVR decline (p < 0.05). Longitudinal changes in CVR were associated with changes in processing speed (p ¼ 0.031) and episodic memory (p ¼ 0.022), but not with working memory or reasoning. The rate of longitudinal CVR change was not different between hypertensive and normotensive participants. However, crosssectionally, individuals with hypertension revealed in a lower CVR compared to normotensive participants (p ¼ 0.016). These findings help elucidate age-related decline in brain hemodynamics and support CVR as a noninvasive biomarker in evaluating cerebrovascular conditions in elderly individuals.
Introduction
Although vascular factors are the second most common cause of dementia in older individuals (Kivipelto et al., 2001) , characteristics of brain vascular changes that occur with aging are still underspecified and poorly understood. Most studies of vascular insults that occur with advanced age have investigated white matter hyperintensities on T2 weighted MRI (Spilt et al., 2005) . These studies have found WMH's increase dramatically at advanced age (Valdes Hernandez Mdel et al., 2013) . However, vascular changes in the gray matter, where most neurocomputation takes place, have not been characterized to date due to the fact that few WMH occur in gray matter. Furthermore, structural lesions such as WMH are late events and are generally only observed at an age of 50 years and above (Debette and Markus, 2010) , and thus are likely insensitive to any vascular changes that occur in the middle age.
One of the most important functions of cerebral vessels is to dilate and constrict dynamically in response to changes in resource demands on the vascular system. Thus, a vasodilatory index, referred to as cerebrovascular reactivity (CVR), can provide a direct assessment of efficient cerebrovascular function (Lu et al., 2011; Tancredi et al., 2012) . Age-related alterations in CVR have been reported (Coverdale et al., 2017; De Vis et al., 2015; Gauthier et al., 2013; Kastrup et al., 1998; Lu et al., 2011; Schieve and Wilson, 1953) . CVR was found to decrease significantly with age, at a rate that was faster than that of perfusion (Lu et al., 2011) . One limitation of the prior studies is that they were cross-sectional in design and only measured age-related CVR differences across subjects and were unable to determine the rate of decline within subjects, and whether rate of decline varied by age or brain region.
Furthermore, it is important to determine if measurement of brain vascular markers such as CVR can predict cognition. If the relationship between CVR and cognitive function can be established, it would further support the potential of CVR as a biomarker in the diagnosis and treatment monitoring of conditions such as vascular cognitive impairment. Prior studies have suggested that processing speed is one of the first cognitive domains affected by cerebrovascular dysfunction (Knopman et al., 2015; Selnes et al., 2009 ), but, to date, there is no evidence whether change in CVR track with decline in cognition.
A central goal of this study was to elucidate the magnitude of change in CVR over a four-year interval in 116 cognitively-normal adults ranging from 20 to 88 years old who were participants in the Dallas Lifespan Brain Study. The study appears to be the first longitudinal study that characterizes both the spatial and temporal properties of CVR. We assessed whether the rate of CVR decline were similar across the brain or rather showed evidence for spatial heterogeneity, differing across major brain lobes. Temporally, We examined age-dependence of the decline rate to identify the period in adult lifespan when CVR decline was the most rapid. Longitudinal changes in CVR were compared to changes in cognitive function in the domains of processing speed, reasoning, working memory, and episodic memory. The CVR data were also analyzed in terms of their association with vascular risk of hypertension.
Material and methods

Participants
The dat were collected as part of a longitudinal aging study, the Dallas Lifespan Brain Study (DLBS). The entire cohort of the DLBS contained 350 participants aged from 20 to 89 years old at Wave 1 (i.e. baseline), with 50 participants in each decade range. Of these, 205 subjects (123 female, 82 male, aged 20-88) elected to receive the CVR MRI scan at Wave 1, which requires a brief inhalation of CO 2 gas mixture inside the MRI scanner. Only these subjects were invited to participate in the Wave 2 (i.e. follow-up) CVR procedures, and 116 (78 female, 38 male, aged 20-88 at Wave1) of them completed Wave 2 CVR. The participants who did not return for Wave 2 were not different from those who returned in terms of age range (p ¼ 0.94), education (p ¼ 0.83), or prevalence of hypertension (p ¼ 0.58), but were found to have a lower mini-mental state exam (MMSE) (p ¼ 0.01). There were also more male participants in the group who did not return (p ¼ 0.02). The interval between the two waves was 4.1 AE 0.2 (range 3.5-4.7) years. The participants did not report any pulmonary, respiratory, neurologic, or psychiatric disorders according to self-completed questionnaires. None of the participants were smokers or had asthma. All participants were considered free of mild cognitive impairment or dementia at year 4 follow-up. The lowest MMSE score of the participants was 25 (N ¼ 2). The highest score of modified Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog) was 12 (N ¼ 1). Demographic information of the participants is summarized in Table 1 . The study was performed in accordance with the local institutional review board, and written informed consent was obtained from all participants.
Hypertension status was obtained by a self-reporting questionnaire. The questionnaire asks: 1) "Do you have a history of hypertension (high blood pressure)?" and 2) "Do you have hypertension (high blood pressure) now?". The participants who answered Yes to both questions were considered a sub-group, HTN current , who are currently hypertensive. Those who answered Yes to the first question but No to the second question were considered another sub-group, HTN past , who has a past history of hypertension but is not currently hypertensive, presumably through effective control by medication. CVR were compared across the sub-groups of participants.
CVR MRI
All experiments were performed on a 3T MR system (Philips Healthcare, Best, The Netherlands). Wave 1 and Wave 2 studies used identical protocols. The volunteers were all fitted with foam pads to reduce head motion. CVR was measured using a hypercapnia challenge established in previous studies Lu et al., 2011; Marshall et al., 2014; Yezhuvath et al., 2009) . Briefly, each subject was fitted with a nose clip and a mouthpiece to ensure mouth breathing. Hypercapnia (5% CO 2 mixed with 21% O 2 and 74% N 2 ) was administered through a plastic bag with a valve to switch between room air and CO 2 mixture. A research assistant was inside the magnet room throughout the experiment to switch the valve and monitor the subject. The subject was instructed to establish a breathing rhythm and try to maintain it throughout the scan. The subject inspired room air and the hypercapnic gas in an interleaved manner similar to a block design fMRI experiment, which was 1-min room air inhalation followed by 1-min CO 2 inhalation, repeated three times with additional 1-min room air inhalation at the end. The total duration was 7 min. This paradigm was previously shown to provide comparable results to paradigms that used longer duration (e.g. 4 mins) of CO 2 breathing (Yezhuvath et al., 2009) , number of slices 160, sagittal slice orientation, and duration 3 min and 57s. Physiologic parameters, including end-tidal (Et) CO 2 , breathing rate, heart rate and arterial oxygenation (Y a ) were recorded during the experiment (MEDRAD; Novametrix Medical Systems).
CVR data processing
CVR data were processed with a general linear model (SPM, University College London, UK), in which the dependent variable was BOLD signal and the regressor was the EtCO 2 time course. CVR in units of % BOLD signal change per mmHg of EtCO 2 change (%BOLD/mmHg CO 2 ) was obtained.
The CVR maps were co-registered to the individual high-resolution T 1 -weighted image, followed by normalization to the Montreal Neurological Institute (MNI) template space. CVR values for major brain lobes, including frontal, temporal, parietal, and occipital, as well as wholebrain, were obtained with a parcellated brain template (TzourioMazoyer et al., 2002) .
Cognitive assessment
Four domains of cognitive function were assessed, including (Robbins et al., 1994) and WAIS-III Letter Number Sequencing (Wechsler, 1997) .
Reasoning was estimated using the Raven's progressive matrices (Raven et al., 1998) , ETS letter sets (Ekstrom et al., 1976) and CANTAB Stockings of Cambridge (Robbins et al., 1994) . Episodic memory was assessed using the modified Hopkins Verbal Learning Task (HVLT) (Brandt, 1991) and the CANTAB (Robbins et al., 1994) Verbal Recognition Memory Task. The details of the procedures for the cognition tests can be found in the Supplementary Material. Standardized z-scores were calculated for each test (an individual's test score minus mean test score divided by standard deviation). Composite measures for each of the four cognitive domains were created by adding the z-scores for all tests assigned to each domains and dividing by the number of tests contributing to that cognitive domain. To evaluate longitudinal changes in cognition, we standardized the scores for each cognitive test by pooling the two scores (Wave 1 and Wave 2) of all participants and applying a z-transformation, and then for each cognitive domain, computed the composite measures at Wave 1 and Wave 2 separately. The difference from Wave 1 to Wave 2 was the longitudinal change score in that cognitive domain.
Statistical analysis
For the first analysis, we investigated the effects of age and test wave on whole-brain CVR in a combined general linear model. Age was treated as a continuous variable and Wave (1 or 2) was treated as a repeated measure with whole-brain CVR as the dependent variable.
The second analyses focused on the rate of CVR change, calculated as (Wave 2 CVR-Wave 1 CVR)/time gap between waves, for individual brain lobes (frontal, parietal, temporal, and occipital). Mixed-design analysis of variance (ANOVA) was performed, treating lobe as a within-subject variable, and age and age 2 as between-subject variables.
The inclusion of both the linear and quadratic terms allows for the assessment of any age-related non-linearity in CVR decline in any lobe. If a significant lobe effect was observed, we further compared pairs of brain lobes using paired Student t-test. If a significant age-related interaction was observed, we tested the age relationship for each lobe separately in the post hoc analyses. Then, to understand the relationship between CVR and cognition, we used a general linear model that included, as variables of interest, both linear and quadratic components for age, change in CVR, and their interactions. Additional control variables included baseline CVR and baseline cognitive performance.
Finally, to examine whether baseline CVR and CVR change may be predictive of hypertension, two regression analyses were performed, using baseline CVR or CVR change as the variable of interest to predict hypertension groups, while controlling for age. In all tests, a p value of 0.05 or less was considered significant.
Results
Dependence of whole-brain CVR on age and wave index
The first analysis examined the evidence for longitudinal change in CVR across the adult lifespan. A multivariable linear model treated age as a continuous variable and wave index (i.e. 1 for baseline and 2 for followup) as a repeated measure. The age effect was modeled for both linear and quadratic effects. Results indicated that, for whole-brain CVR, the Age, but not Age 2 , was significant and occurred because whole-brain CVR decreased significantly with increased age (p < 0.001). The Wave effect was also significant because CVR decreased from Wave 1 to Wave 2 (p ¼ 0.002). The Age x Wave interaction did not approach significance for either the linear or quadratic effect. Fig. 1a depicts the systematic agerelated decrease in CVR from the 20's through the 70's for both Wave 1 and 2. Annual change rate for the whole-brain CVR across the four years was À0.0024 AE 0.0009 %BOLD/mmHg/year (mean AE SE), which is equivalent to À0.99 AE 0.39%/year in relative units. Fig. 1b displays scatterplot of whole-brain gray matter (GM) CVR between Wave 1 and Wave 2. Cross correlation coefficient between CVR values of the two Waves was 0.67 (p < 0.001).
Longitudinal changes in CVR across brain lobes
For the next analysis, we assessed whether the CVR change differed across brain lobes and whether there were age-related interactions. The analysis yielded a significant main effect of lobe (p ¼ 0.003) on the rate of CVR declines. Fig. 2 shows that CVR decline rate varied across the major brain lobes. Comparisons indicated that the temporal lobe showed a faster decline rate than the frontal (p ¼ 0.001) and occipital lobes (p < 0.001), with a trend-level effect towards faster decline compared to the parietal lobe (p ¼ 0.087). Additional comparisons indicated that parietal lobe had a faster decline rate than occipital lobe (p < 0.001), with a trend difference when compared to the frontal lobe (p ¼ .098). The occipital lobe was found to have the slowest rate of CVR decline among the major brain lobes investigated, and the decline rate was not significantly different from zero (p ¼ 0.344, Fig. 2) .
The linear component of the Age x Lobe interaction was not significant (p ¼ 0.304), but the quadratic component was significant (Age  2 x Lobe interaction, p ¼ 0.011). The quadratic effect applied only to the temporal (p ¼ 0.027, Fig. 3 left panel) and occipital lobes (p ¼ 0.015, Fig. 3 right panel) , whereas the rate of decline in CVR was unaffected by age for the frontal (p ¼ .406) and parietal lobes (p ¼ .162). In sum, the analysis showed the temporal lobe was most sensitive to decline in CVR and that the greatest decline occurred during middle age.
Longitudinal CVR change and cognitive change
For the next set of analyses, we used the general linear model described earlier to examine whether changes in CVR across the fouryear interval were predictive of cognitive decline during the same period. First, we examined whether whole brain CVR decline predicted changes in four domains of cognition. Results indicated that whole brain CVR decline significantly predicted declines in processing speed (p ¼ 0.031, Fig. 4a ) and episodic memory (p ¼ 0.022, Fig. 4b ). Based on these findings, we looked at whether the effects for processing speed and episodic memory were qualified by brain lobe. Results indicated that change in CVR in the temporal lobe (p ¼ 0.033) and the frontal lobe (p ¼ 0.039) predicted change in processing speed. Moreover, both the parietal (p ¼ 0.080) and occipital lobes (p ¼ 0.055) showed marginal significance. This widespread CVR change effect on processing speed was consistent across the lifespan since no age interaction was found in any lobes (p > 0.1).
Similarly, the relationship between CVR change and episodic memory change was also widespread across lobes (temporal: p ¼ 0.019, occipital: p ¼ 0.020, parietal: p ¼ 0.053). There was a significant Age x CVR change interaction on memory change in the occipital lobe (p ¼ 0.029) such that the CVR declines were more predictive of memory declines relationship in younger adults.
The relationship between CVR and hypertension
We assessed both the baseline relationship, as well as the longitudinal change in CVR, to hypertension. A total of 21 participants (mean age 68.1 AE 13.5) reported themselves to be currently hypertensive (HTN current ), 20 of whom were taking anti-hyptertensive medications. An additional 14 participants (age 62.2 AE 19.1) reported that they had a past history of hypertension but were not currently hypertensive (HTN past ), none of whom were taking anti-hypertensive medications. These subgroups were compared to an age-matched (55 years and above) normotensive group (N ¼ 58, age 69.3 AE 8.9). As expected, the lowest baseline CVR occurred in the current hypertensives. Both the past hypertensives and normotensives had significantly higher CVR than the current hypertensives (p ¼ 0.016 and 0.025 respectively), and did not differ significantly from each other (Fig. 5) . Longitudinal change in CVR was not associated with hypertensive status.
Discussion
This study presented longitudinal changes in cerebrovascular reactivity over four years in an across adult lifespan sample, and examined its relationship to cognition. Previous studies have reported that WMH volume increases with age (Spilt et al., 2005) and that CBF decreases with age (Chen et al., 2011; Lu et al., 2011) . However, less has been known about longitudinal change in cerebrovascular reactivity. The design of the present study provides longitudinal data about cerebrovascular change in young, middle age, and older adults. Since CVR measures vasodilatory capacity of blood vessels, the observed changes in the present study likely reflect a thickening and hardening of the walls, as well as narrowing of the vessels. We report the following major findings. 1) There is detectable decline in CVR over four years across the lifespan. 2) The temporal lobe revealed the fastest decline in cerebrovascular reactivity, while the occipital lobe was the most preserved.
3) The greatest rate of CVR decline occurred in the temporal lobe during middle age. 4) Decline in cerebrovascular reactivity is related to declines in cognition, particularly processing speed and episodic memory.
In support of our first finding, we initially used the whole brain to calculate longitudinal change in global CVR and found evidence for significant decline in CVR between wave 1 and wave 2, as well as agedifferences previously reported (Lu et al., 2011) . However, cerebrovascular changes are known to be heterogeneous across brain regions. For example, occipital lobe has been shown to have both the least amount of longitudinal WMH and volumetric shrinkage (Raz et al., 2005 (Raz et al., , 2012 , as well as relatively preserved hemodynamic function (D'Esposito et al., 1999) . Additionally, previous studies on CBF have shown that resting brain perfusion shows the most pronounced age effect in the frontal lobe (Beason-Held et al., 2009; Chen et al., 2011; Lu et al., 2011) , particularly in the prefrontal cortex.
Hence, we examined change in CVR as a function of brain lobe. The analysis provided the evidence that occipital lobe had the least change in cerebrovascular function, whereas the fastest CVR decline was observed in the temporal lobe (followed by parietal lobe). Importantly, the analysis by lobe revealed that there were age differences in rate of change. Surprisingly, the greatest decline in CVR did not occur in old age, but rather in middle age, a finding that could not be detected without a lifespan longitudinal design. These findings are similar to those reported by Raz et al. (2012) who found changes in WMH volume over a period of 30 months, and showed that the rate of WMH volume expansion in middle-aged adults was greater than that at older ages.
Examination of the effect of hypertension on CVR revealed that hypertension is associated with a lower CVR, suggest that CVR may be a useful biomarker in indexing the impact of systemic vascular risks on the brain. More interestingly, we observed that individuals with a history of hypertension, but whose BP is well controlled by medication, had a significant higher CVR than those whose BP is poorly controlled. This finding is in good agreement with reports of Muller et al. (Muller et al., 2012) that global blood flow declines faster in untreated or poorly controlled hypertensive individuals than those with controlled hypertension. A possible mechanism is that vascular smooth muscle tone is mediated by nitric oxide (NO) derived from endothelial cells and neuron (Faraci and Brian, 1994) and patients with hypertension are characterized by reduced bioavailability of NO, leading to reduced CVR (Bomboi et al., 2010) . With antihypertensive medication, improved endothelial function and NO formation have been shown in animal studies (Oyama et al., 2010) . The observation in the present study provides evidence that CVR is a modifiable imaging biomarker, as compared to WMH which is thought to be irreversible (Debette and Markus, 2010) . These features afford CVR a potential endpoint in clinical trials of cerebrovascular conditions.
Although vascular dementia is the second leading cause of cognitive disability in older adults (after Alzheimer's type), associations between cerebrovascular biomarkers and cognition have not been well studied. In a cross-sectional study with a large sample of 1906 older participants (age 76 AE 5 years), Knopman and colleagues (Knopman et al., 2015) reported that higher WMH volume was most significantly associated with deficits in processing speed, but not with memory. Our longitudinal CVR data revealed a similar association between changes in CVR and processing speed, the most sensitive cognitive marker of aging (Park et al., 2002; Salthouse, 1996) , using a sample size that was substantially smaller. Not only was there a global relationship in whole brain CVR to processing speed, significant associations were found in both temporal and frontal lobes, with marginal significance in the remaining two. Of equal importance was the finding that declines in CVR also track significantly with decline in episodic memory in temporal, parietal and occipital lobes, a finding not reported by Knopman et al. (2015) for WMH. Therefore, it is plausible that CVR may be a more sensitive vascular biomarker than WMH in predicting cognitive changes. These findings also suggest that processing speed and episodic memory are among the most vulnerable cognitive domains to cerebrovascular dysfunction.
Finally, the findings from the present study highlight the importance of studying the entire adult lifespan to understand the effects of aging on the brain. Because middle aged adults have rarely been subjects of most brain imaging studies, particularly longitudinal studies, we know little about when exactly in adulthood brain changes occur. The Dallas Lifespan Brain Study is providing increasing evidence that there are important differences during middle age in brain function (Chan et al., 2014; Park et al., 2013) .
Strengths of our study include a large sample size (116 participants), that it has four-year longitudinal follow-up data, and that data of all participants and time points were collected at a single-site on one MRI system, which ensures data harmonization and compatibility. Our cognitive tests were comprehensive and included multiple cognitive domains with each domain consisting of multiple tasks.
Several limitation of current study should be acknowledged. First, the present study only examined CVR as an index of cerebrovascular function, but did not investigate corresponding changes in other vascular imaging biomarkers such as WMH volume or CBF. Future studies should compare the temporal trajectory of these different vascular parameters. A second limitation is that the follow-up period, four years, was not as long as some of the earlier studies (Gottesman et al., 2014; Nyberg et al., 2010) . However, we note that the present study is the first longitudinal investigation of CVR imaging index to date, and we are currently in the process of planning for a Wave 3 study, which should manifest more longitudinal changes in both CVR and cognition. Nevertheless, we still observed longitudinal decline in CVR over this relatively short period, and its association with cognitive decline widespread across the brain, which may suggest CVR being a more specific and sensitive vascular marker than WMH and CBF. Finally, we point out that, during our CVR experiment, we did not control for other vasoactive factors such as consumption of caffeine. This could add noise or bias to our data, although some previous studies have suggested a minimal effect of caffeine consumption on CVR measurement (Chen and Parrish, 2009) .
Conclusions
The present work showed that CVR, a biomarker of cerebral vasodilatory function, decreases with age. Longitudinal decline in vascular function was most pronounced in the middle age and spatially it was most prominent in the temporal lobe. Longitudinal change in CVR is HTN past ) (N ¼ 14) . The error bars indicate standard errors. *: p < 0.05. strongly associated with changes in processing speed and episodic memory, suggesting the potential of CVR imaging measure as a useful biomarker indicating cerebrovascular conditions related to cognitive changes.
